Improving COVID-19 vaccine coverage in patients with autoimmune and inflammatory diseases

J Rheumatol. 2021 Oct 15:jrheum.210534. doi: 10.3899/jrheum.210534. Online ahead of print.ABSTRACTIn the current SARS Cov-2 pandemic context, vaccination using mRNA Covid-19 vaccine has started in France in December 2020. Based on the risk for severe COVID-19, patients suffering from autoimmune diseases (AID) and receiving -or about to receive- steroids or immunosuppressive drugs have been prioritized for vaccination (1).PMID:34654731 | DOI:10.3899/jrheum.210534

Source: Journal of Rheumatology - October 16, 2021 Category: Rheumatology Authors: Tiphaine Goulenok Chrystelle Francois C éline Mendes Fatima Farhi Jean-Francois Alexandra Diane Rouzaud Thomas Papo Karim Sacre Source Type: research